Share on StockTwits

Egalet Corp (NASDAQ:EGLT) Insider Mark Strobeck sold 5,135 shares of Egalet Corp stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $9.20, for a total value of $47,242.00. Following the completion of the transaction, the insider now directly owns 125,280 shares of the company’s stock, valued at approximately $1,152,576. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Egalet Corp (NASDAQ:EGLT) opened at 8.84 on Monday. Egalet Corp has a one year low of $8.75 and a one year high of $19.85. The stock’s 50-day moving average is $11.95 and its 200-day moving average is $12.89. The company’s market cap is $140.4 million.

Egalet Corp (NASDAQ:EGLT) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.73) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.42) by $0.31. On average, analysts predict that Egalet Corp will post $-3.51 earnings per share for the current fiscal year.

Egalet Corporation is a specialty pharmaceutical company developing and focuses on commercializing, abuse-deterrent oral products for the treatment of pain and in other indications.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.